Stocks and Investing
Stocks and Investing
Fri, May 7, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 6, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Fein Maintained (UTHR) at Strong Buy with Increased Target to $248 on, May 6th, 2021
Andrew Fein of HC Wainwright & Co., Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Increased Target from $195 to $248 on, May 6th, 2021.
Andrew has made no other calls on UTHR in the last 4 months.
There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Andrew
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $212 on, Thursday, April 8th, 2021
- Martin Auster of "Credit Suisse" Maintained at Buy with Increased Target to $196 on, Monday, February 22nd, 2021
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $275 on, Tuesday, February 16th, 2021
Contributing Sources